LUTHERAN MUSCULOSKELETAL CENTER — History
CCN 150168 | 3-year financial timeline | COVID resilience: 68/100
🛡️ Public data only — no PHI permitted on this instance.
$169M
Latest Revenue (FY2022)
+16.0%
Revenue CAGR (3yr)
25.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $125M | $145M | $169M | +16.8% | +16.0% |
| Operating Expenses | $95M | $110M | $127M | +15.0% | +15.3% |
| Operating Margin | 24.1% | 23.8% | 25.0% | +4.8% | +1.9% |
| Net Income | $30M | $34M | $42M | +22.4% | +18.3% |
| Licensed Beds | 39 | 39 | 39 | +0.0% | +0.0% |
| Total Patient Days | 3,560 | 3,696 | 3,823 | +3.4% | +3.6% |
| Medicare Day % | 25% | 21% | 23% | +7.9% | -3.9% |
| Medicaid Day % | 8% | 8% | 9% | +12.5% | +6.8% |
COVID Impact & Recovery
Resilience Score: 68/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +34.6% ($125M → $169M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+16.0%
This Hospital
+7.6%
State Avg
Latest Margin
25.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $191M | 25.5% |
| FY2024 (proj) | $212M | 25.9% |
| FY2025 (proj) | $234M | 26.4% |